0.4790
+0.0230
+(5.04%)
At close: April 11 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.26 | -0.14 | -0.65 | -1.05 |
| Low Estimate | -0.26 | -0.14 | -0.65 | -1.05 |
| High Estimate | -0.26 | -0.14 | -0.65 | -1.05 |
| Year Ago EPS | -0.08 | 0.01 | -0.23 | -0.65 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 2 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | 10.69M | 13.85M | 41.09M | -- |
| Sales Growth (year/est) | -100.00% | -100.00% | -100.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.11 | -0.13 | 0.14 | -0.31 |
| EPS Actual | -0.08 | 0.01 | 0 | -0.16 |
| Difference | 0.03 | 0.14 | -0.14 | 0.15 |
| Surprise % | 25.00% | 107.89% | -100.00% | 48.39% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.26 | -0.14 | -0.65 | -1.05 |
| 7 Days Ago | 0 | 0 | -0.86 | 0 |
| 30 Days Ago | -0.19 | -0.19 | -0.83 | 0 |
| 60 Days Ago | -0.19 | -0.19 | -1.07 | 0 |
| 90 Days Ago | -0.19 | -0.19 | -1.07 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | -- |
| Up Last 30 Days | -- | -- | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| EQ | -225.00% | -1,500.00% | -182.61% | -61.54% |
| S&P 500 | 6.76% | 5.77% | 9.23% | 14.19% |
Upgrades & Downgrades
| Downgrade | Leerink Partners: Outperform to Market Perform | 3/28/2025 |
| Downgrade | Jones Trading: Buy to Hold | 11/1/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/19/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 6/5/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/17/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 4/2/2024 |
Related Tickers
SPRC SciSparc Ltd.
0.2836
+3.58%
IMRN Immuron Limited
1.7000
+4.29%
CTNM Contineum Therapeutics, Inc.
4.0100
-2.91%
PHRRF PharmaTher Holdings Ltd.
0.1400
+4.48%
PXMD PaxMedica, Inc.
0.0002
0.00%
MBIO Mustang Bio, Inc.
1.3900
+4.51%
MTNB Matinas BioPharma Holdings, Inc.
0.5400
+5.32%
LIXT Lixte Biotechnology Holdings, Inc.
1.2100
+3.42%
GRCE Grace Therapeutics, Inc.
1.9799
+1.02%
EYEN Eyenovia, Inc.
0.9500
-1.57%